Pharmacists' experiences on adverse drug reaction: 10 years later

被引:2
|
作者
Karuppannan, Mahmathi [1 ]
Rizal, Nur Azzrin Nisha Mohamad [2 ]
Wong, Kok-Thong [3 ]
Ali, Salmiah Mohd [4 ]
Ting, Kang-Nee [3 ]
Boardman, Helen [5 ]
机构
[1] Univ Teknol MARA UiTM Cawangan Selangor, Fac Pharm, Dept Pharm Practice, Puncak Alam Campus, Shah Alam, Malaysia
[2] Hosp Sultanah Nora Ismail, Batu Pahat, Malaysia
[3] Univ Nottingham Malaysia, Sch Pharm, Semenyih, Malaysia
[4] Asian Metropolitan Univ, Kuala Lumpur, Malaysia
[5] Univ Nottingham, Sch Pharm, Div Pharm Practice & Policy, Nottingham, England
关键词
adverse drug reaction; pharmacists; community pharmacists; reporting ADRs; survey; COMMUNITY PHARMACISTS; KNOWLEDGE; PHARMACOVIGILANCE; PREVALENCE; ATTITUDES; ADMISSION; BARRIERS;
D O I
10.3389/fphar.2022.932942
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adverse drug reaction (ADR) is one of the leading public health concerns associated with high mortality rate. Healthcare professionals, particularly pharmacists, have a significant role in monitoring and preventing ADRs. This study was conducted on Malaysian Pharmaceutical Society (MPS) pharmacists who worked at the hospitals, health clinics, and community pharmacies to determine if pharmacists' experiences on ADRs are still the same 10 years later. In 2010, a postal survey and in 2020, an online survey were conducted among these pharmacists. A total of 472 pharmacists and 208 participated in 2010 and 2020, respectively. About 82% and 90% of hospital/health clinic pharmacists (HCPs) observed an ADR over the last 6 months in 2010 and 2020, while 60% and 100% community pharmacists in 2010 and 2020 observed an ADR, respectively. Perindopril was the top drug (HCPs: p = 0.657; CPs: p = 0.98), and rash was the top ADR reported by the pharmacists in both years (HCPs: p < 0.001; CPs: p = 0.679). The most common actions taken by HCPs in 2010 were to report the ADR (p = 0.343), while in 2020, most HCPs explained to patients regarding the reaction (p = 0.061), which was also the same in the CP group in 2020 (p = 0.958). The top factor encouraging ADR reporting in both years and both pharmacist groups was the high degree of severity of the reaction (HCPs: p < 0.001; CPs: p = 0.769). While the top factors discouraging ADR reporting were a lack of information from the affected patients (HCPs: p = 0.2; CPs: p = 0.656), reaction is widely known (HCPs: p = 0.001; CPs: p = 0.144) and uncertainty of the causal relationship (HCPs: p = 0.169; CPs: p = 0.609). Majority of the pharmacists agreed that severe reactions should be reported (HCPs: p = 0.158; CPs: p = 0.501) and the main aim for reporting is to measure the incidence of ADRs (HCPs: p = 0.148; CPs: p = 0.762). Despite being able to identify ADRs during the daily practice, many pharmacists especially community pharmacists are not reporting them. There is a misconception on the purpose of reporting ADRs. An interventional program and ADR reporting training would be a useful step in improving ADR reporting practice.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Do community pharmacists in Nepal have a role in adverse drug reaction reporting systems?
    Bhuvan, K. C.
    Alrasheedy, Alian A.
    Ibrahim, Mohamed Izham Mohamed
    AUSTRALASIAN MEDICAL JOURNAL, 2013, 6 (02): : 100 - 103
  • [32] Community pharmacists' challenges regarding adverse drug reaction reporting: an example from Serbia
    Kusturica, Paut M.
    Stilinovic, N.
    Tomas, A.
    Panjkovic, K.
    Raskovic, A.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S124 - S124
  • [33] A national viewpoint of community pharmacists of pharmacovigilance and adverse drug reaction reporting in Saudi Arabia
    Alasmari, Moudi M.
    Alsheikh, Mona Y.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 226 - 226
  • [34] Factors that affect adverse drug reaction reporting among hospital pharmacists in Western China
    Jun Liu
    Zhongliang Zhou
    Shimin Yang
    Bianling Feng
    Jun Zhao
    Hua Liu
    Haiyan Huang
    Yu Fang
    International Journal of Clinical Pharmacy, 2015, 37 : 457 - 464
  • [35] Factors that could affect adverse drug reaction reporting by community pharmacists in Southern Portugal
    Pinheiro, L. C.
    Caneira, M.
    Martins, A. P.
    Cabrita, J.
    Morais, J. A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S119 - S119
  • [36] Factors that affect adverse drug reaction reporting among hospital pharmacists in Western China
    Liu, Jun
    Zhou, Zhongliang
    Yang, Shimin
    Feng, Bianling
    Zhao, Jun
    Liu, Hua
    Huang, Haiyan
    Fang, Yu
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (03) : 457 - 464
  • [37] Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China
    Su, Changhai
    Ji, Hui
    Su, Yixin
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (03) : 217 - 222
  • [39] Belimumab 10 years later: how drug positioning has changed
    Ceccarelli, Fulvia
    Natalucci, Francesco
    Ciancarella, Claudia
    Picciariello, Licia
    Moretti, Valeria
    Spinelli, Francesca Romana
    Alessandri, Cristiano
    Conti, Fabrizio
    IMMUNOLOGIC RESEARCH, 2024, 72 (06) : 1441 - 1446
  • [40] Frequency and nature of drug related problems in psychiatry: 10 years later
    Barrak, Akram
    De Beauchamp, Isabelle
    Alberto, Marie-Christine
    PHARMACY WORLD & SCIENCE, 2008, 30 (05): : 695 - 695